College of Medicine
Harrison Lab
Led by Jeffrey K Harrison · Pharmacology and Therapeutics
What we study
The Harrison Lab studies how immune cells contribute to brain tumor growth and resistance to treatments. They focus on myeloid cells in gliomas, using in vitro and in vivo methods, including chemokine receptor antagonists.
What working here is like
- Wet lab
- Mice
- Project
- 1
- Papers
- 3
Current projects
Chemokine receptor antagonists for glioblastoma
Developing treatments targeting chemokine receptors to combat immune resistance in brain tumors.
Summaries are written by AI in plain language from public symposium abstracts and may be imperfect.
Recent papers, explained
- Engineering pH-Responsive Dendrimer–STAT3 Inhibitor Conjugates for Intracellular Delivery
2025 · Biomacromolecules
Creates drug-dendrimer conjugates that release drugs inside cells at low pH.
- CSF1R Ligands Expressed by Murine Gliomas Promote M-MDSCs to Suppress CD8+ T Cells in a NOS-Dependent Manner
2024 · Cancers
Shows how brain tumor cells use immune-suppressing cells to evade the immune system.
Show 1 more papersShow fewer
- Optimal control of combination immunotherapy for a virtual murine cohort in a glioblastoma-immune dynamics model
2024 · Journal of Theoretical Biology
Uses math to design the best drug combo for treating brain cancer.
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Jeffrey K Harrison hasn't set up this page yet. Their UF Scholars profile lists their publications.